Studies on the inhibition of human cytochromes P450 by selenocysteine Se -conjugates

References

• ANDREADOU, I., MENGE, W. M. P. B., COMMANDEUR, J. N. M., WORTHINGTON, E. A. and VERMEULEN, N. P. E., 1996, Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: evaluation of kinetics of 13-elimination reactions in rat renal cytosol. Journal of Medicinal Chemistry, 39, 2040–2046.
   Google Scholar
• BRENNER, M. and HUBER, W., 1953. Herstellung von a-aminosdureestem durch alkoholyse der methylester. Helvetica, 36, 1109–1115.
   Web of Science ®Google Scholar
• COMMANDEUR, J. N. M., ANDREADOU, I., ROOSEBOOM, M., OUT, M., DE LEUR, L. J., GROOT, E. and VERMEULEN, N. P. E., 2000, Bioactivation of selenocysteine Se-conjugates by a highly purified rat renal cysteine conjugate beta-lyase/glutamine transaminase K. Journal of Pharmacology and Experimental Therapeutics, 294,753–761.
   Google Scholar
• COMMANDEUR, J. N. M., STIJNTJES, G. J. and VERMEULEN, N. P. E., 1995, Enzymes and transport systems involved in the formation and disposition of glutathione-S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacological Reviews, 47, 271–330.
   Google Scholar
• CONAWAY, C. C., JIAO, D. and CHUNG, F. L., 1996, Inhibition of rat liver cytochrome P450 isoenzymes by isothiocyanates and their conjugates: a structure—activity relationship study. Carcinogenesis, 17, 2423–2427.
   PubMed Web of Science ®Google Scholar
• CRESPI, C. L., 1999, Higher-throughput screening with human cytochromes P450. Current Opinion in Drug Discovery and Development, 2, 15–19.
   PubMedGoogle Scholar
• CRESPI, C. L., MILLER, V. P. and PENMAN, B. W., 1997, Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Analytical Biochemistry, 248, 188–190.
   PubMed Web of Science ®Google Scholar
• CRESPI, C. L. and STRESSER, D. M., 2000, Fluorimetric screening for metabolism-based drug—drug interactions. Journal of Pharmacological and Toxicological Methods, 44, 325–331.
   PubMed Web of Science ®Google Scholar
• EL-BAYOUMY, K., 1985, Effects of organoselenium compounds on mouse forestomach tumors by benzo[a]pyrene. Cancer Research, 45, 3631–3635.
   PubMed Web of Science ®Google Scholar
• EL-BAYOUMY, K., UPADHYAYA, P., CHAE, Y. H., SOHN, O. S., RAO, C. V., FIALA, E. and REDDY, B. S., 1995, Chemoprevention of cancer by organoselenium compounds. Journal of Cellular Biochemistry, 22 (suppl.), 92–100.
   Google Scholar
• GANTHER, H. E., 1999, Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis, 20, 1657–1666.
   Google Scholar
• GOEPTAR, A. R., SCHEERENS, H. and VERMEULEN, N. P. E., 1995, Oxygen and xenobiotic reductase activities of cytochrome P450. Critical Reviews in Toxicology, 25,25–65.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
   PubMed Web of Science ®Google Scholar
• HOLLENBERG, P. F., 2002, Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metabolism Reviews, 34, 17–35.
   PubMed Web of Science ®Google Scholar
• HYSLOP, P. A. and SKLAR, L. A., 1984, A quantitative fiuorimetric assay for the determination of oxygen production by polymorpho-nuclear leukocytes: its use in the simultaneous fiuorimetric assay of cellular activation processes. Analytical Biochemistry, 141, 280–286.
   PubMed Web of Science ®Google Scholar
• INGELMAN-SUNDBERG, M., OSCARSON, M. and MCLELLAN, R. A., 1999, Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends in Pharmacological Sciences, 20, 342–349.
   PubMed Web of Science ®Google Scholar
• IOANNIDES, C. and PARKE, D. V., 1993, Induction of cytochrome P450 as an indicator of potential chemical carcinogenesis. Drug Metabolism Reviews, 25, 485–501.
   PubMed Web of Science ®Google Scholar
• IP, C., 1998, Lessons from basic research in selenium and cancer prevention. Journal of Nutrition, 128, 1845–1854.
   PubMed Web of Science ®Google Scholar
• IP, C. and LisK, D. J., 1997, Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. Nutrition and Cancer, 28, 184–188.
   PubMed Web of Science ®Google Scholar
• IP, C., VADHANAVIKIT, S. and GANTHER, H. E., 1995, Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts. Carcinogenesis, 16, 35–38.
   PubMed Web of Science ®Google Scholar
• IP, C., ZHU, Z., THOMPSON, H. J., Lisx, D. and GANTHER, H. E., 1999, Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Research, 19, 2875–2880.
   PubMed Web of Science ®Google Scholar
• JIANG, C., JIANG, W., IP, C., GANTHER, H. E. and Lu, J., 1999, Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Molecular Carcinogenesis, 26, 213–225.
   PubMed Web of Science ®Google Scholar
• JIAO, D., CONAWAY, C. C., WANG, M. H., YANG, C. S., KOEHL, W. and CHUNG, F. L., 1996, Inhibition of N-nitrosodimethylamine demethylase in rat and human liver microsomes by isothiocyanates and their glutathione, L-cysteine, and N-acetyl-L-cysteine conjugates. Chemical Research in Toxicology, 9, 932–938.
   PubMed Web of Science ®Google Scholar
• KAWAJIRI, K. and HAYASHI,1997, The CYP1 family. In C. Ioannides (ed.), Cytochromes P450:Metabolic and Toxicological Aspects (London: CRC Press), pp. 77–97.
   Google Scholar
• KENT, U. M., JUSCHYSHYN, M. I. and HOLLENBERG, F. P., 2001, Mechanism-based inactivators as probes of cytochrome P450 structure and function. Current Drug Metabolism, 2, 215–243.
   PubMed Web of Science ®Google Scholar
• Lu, J. X., PEI, H. Y., LISK, D. J., GANTHER, H. and THOMPSON, H. J., 1996, Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis, 17, 1903–1907.
   PubMed Web of Science ®Google Scholar
• MUGESH, G., DU MONT, W.-W. and SIES, H., 2001, Chemistry of important organoselenium compounds. Chemical Reviews, 101, 2125–2179.
   Google Scholar
• PROKOPCZYK, B., Cox, J. E., UPADHYAYA, P., AMIN, S., DESAI, D., HOFFMANN, D. and EL-BAYOUMY, K., 1996, Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridy1)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis, 17, 749–753.
   Google Scholar
• PUNTAROLA, S. and CEDERBAUM, A. I., 1998, Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radical Biology and Medicine, 24, 1324–1330.
   PubMedGoogle Scholar
• RIPP, S. L., OVERBY, L. H., PHILPOT, R. M. and ELFARRA, A. A., 1997, Oxidation of cysteine 5-conjugates by rabbit liver microsomes and cDNA expressed fiavin-containing mono-oxygenases: studies with S-(1,2-dichloroviny1)-L-cysteine, S-(1,2,2-trichloroviny1)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine. Molecular Pharmacology, 51, 507–515.
   PubMed Web of Science ®Google Scholar
• ROOSEBOOM, M., COMMANDEUR, J. N. M., FLOOR, G. C., RETTIE, A. E. and VERMEULEN, N. P. E., 2001, Selenoxidation by fiavin-containing monooxygenases as a novel pathway for 13-elimination of selenocysteine Se-conjugates. Chemical Research in Toxicology, 14, 127–134.
   Google Scholar
• ROOSEBOOM, M., VERMEULEN, N. P. E., ANDREADOU, I. and COMMANDEUR, J. N. M., 2000, Evaluation of the kinetics of 13-elimination reactions of selenocysteine Se-conjugates in human renal cytosol: possible implications for the use as kidney selective prodrugs. Journal of Pharmacology and Experimental Therapeutics, 294, 762–769.
   Google Scholar
• SAUSEN, P. J. and ELFARRA, A. A., 1990, Cysteine conjugate S-oxidase. Characterization of a novel enzymatic activity in rat hepatic and renal microsomes. Journal of Biological Chemistry, 265, 6139–6145.
   PubMed Web of Science ®Google Scholar
• SCHAER, E. M., Liu, J. Z., DANGLER, C. A. and MILNER, J. A., 1996, Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced mammary carcinogenesis. Cancer Letters, 102, 199–204.
   PubMedGoogle Scholar
• SCHLEZINGER, J. J., WHITE, R. D. and STEGEMAN, J. J., 1999, Oxidative inactivation of cytochrome P-450 1A (CYP1A1 ) stimulated by 3,31,4,41-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1 As. Molecular Pharmacology, 56, 588–597.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ, D., KISSELEV, P., CASCORB I., SCHUNK, W.-H. and ROOTS, I., 2001, Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis, 22, 453–459.
   Google Scholar
• SHIMADA, T., EL-BAYOUMY, K., UPADHYAYA, P., SUTTER, T. R., GUENGERICH, F. P. and YAMAZAKI, H., 1997, Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer Research, 57, 4757–4764.
   Google Scholar
• SPATZENEGGER, M. and JAEGER, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews, 27, 397–417.
   PubMed Web of Science ®Google Scholar
• SUMIOKA, I., MATSURA, T., KASUGA, S., ITAKURA, Y. and YAMADA, K., 1998, Mechanism of protection of S-allylmercaptocysteine against acetaminophen-induced liver injury in mice. Japanese Journal of Pharmacology, 78, 199–207.
   PubMedGoogle Scholar
• TALALAY, P., FAHEY, J. W., HOLTZCLAW, W. D., PRESTERA, T. and ZHANG, Y., 1995, Chemoprotection against cancer by phase 2 enzyme induction. Toxicology Letters, 82–83, 173–179.
   Google Scholar
• 'T HOEN, P. A., ROOSEBOOM, M., BIJSTERBOSCH, M. K., VAN BERKEL, T. J., VERMEULEN, N. P. E., COMMANDEUR, J. N. M., 2002, Induction of glutathione-S-transferase in RNA levels by chemopreventive selenocysteine Se-conjugates. Biochemical Pharmacology, 63, 1843–1849.
   Google Scholar
• VENHORST, J., ONDERWATER, R. C. A., MEERMAN, J. H. N., COMMANDEUR, J. N. M. and VERMEULEN, N. P. E., 2000, Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metabolism and Disposition, 28, 1524–1532.
   Google Scholar
• WERNER, M., BIRNER, G. and DEKANT, W., 1996, Sulfoxidation of mercapturic acids derived from tri-and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage. Chemical Research in Toxicology, 9, 41–49.
   PubMed Web of Science ®Google Scholar
• WERNER, M., Guo, Z., BIRNER, G., DEKANT, W. and GUENGERICH, F. P., 1995, The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadieny1)-L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chemical Research in Toxicology, 8, 917–923.
   PubMed Web of Science ®Google Scholar
• YAMAUCHI, A., STIJNTJES, G. J., COMMANDEUR, J. M. N. and VERMEULEN, N. P. E., 1993, Purification of glutamine transaminase K/cysteine conjugate fl-lyase from rat renal cytosol based on hydrophobic interaction HPLC and gel permeation FPLC. Protein Expression and Purification, 4, 552–562.
   Google Scholar